LORAZEPAM Spirig HC cpr 2.5 mg 20 pce
7680696820033
CH-69682
N05BA06
01.04.1.
Reimbursement limitations:
120PISL
Prescription limitée au maximum à 120 points. Iniectabilia sine limitatione
1 / 3
google
Details
- Product number
- 6968202
- CPT
- -
- Packaging group
- 20
- Unit
- Tablette(n)
- Composition
- lorazepamum 2.5 mg, lactosum monohydricum 122.8 mg, cellulosum microcristallinum, polacrilinum kalicum, magnesii stearas, E 172 (flavum), pro compresso.
Articles (1)
Lorazepam Spirig HC 2.5 mg, Tabletten
Tabletten
20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
122.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 12.20
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2025
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69682
- Drug name
- Lorazepam Spirig HC, Tabletten
- Galenic form
- TAB
- ATC Code
- N05BA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/08/2024
- Authorization expiration date
- 21/08/2029
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LORAZEPAM Spirig HC cpr 2.5 mg 20 pce
- Description (DE)
- LORAZEPAM Spirig HC Tabl 2.5 mg 20 Stk
- Market launch
- 22/08/2024
- Narcotic (BTM)
- B